https://orcid.org/0000-0001-5848-0607
References
- Clark P, Tamayo JA, Cisneros F, et al. Epidemiology of osteoporosis in Mexico. Present and future directions. Rev Invest Clin. 2013;65:183–191.
- Roshandel D, Holliday KL, Pye SR, et al. Genetic variation in the RANKL/RANK/OPG signaling pathway is associated with bone turnover and bone mineral density in men. J Bone Miner Res. 2010;25:1830–1838.
- Strom TM, Wienker TF. Hardy-Weinberg equilibrium online analysis program. [Internet] 2017 Available from: http://ihg.gsf.de/cgi-bin/hw/hwa1.pl [last accessed Jan 2017].
- Liu JM, Zhang MJ, Zhao L, et al. Analysis of recently identified osteoporosis susceptibility genes in Han Chinese women. J Clin Endocrinol Metab. 2010;95:E112–E120.
- Shang M, Lin L, Cui H. Association of genetic polymorphisms of RANK, RANKL and OPG with bone mineral density in Chinese peri- and postmenopausal women. Clin Biochem. 2013;46:1493–1501.
- Paternoster L, Ohlsson C, Sayers A, et al. OPG and RANK polymorphisms are both associated with cortical bone mineral density: findings from a metaanalysis of the avon longitudinal study of parents and children and gothenburg osteoporosis and obesity determinants cohorts. J Clin Endocrinol Metab. 2010;95:3940–3948.
- Kemp JP, Sayers A, Paternoster L, et al. Does bone resorption stimulate periosteal expansion? a cross‐sectional analysis of β‐C‐telopeptides of type i collagen (CTX), genetic markers of the RANKL pathway, and periosteal circumference as measured by pQCT. J Bone Miner Res. 2014;29:1015–1024.
- Styrkarsdottir U, Halldorsson BV, Gretarsdottir S, et al. Multiple genetic loci for bone mineral density and fractures. N Engl J Med. 2008;358:2355–2365.
- Styrkarsdottir U, Halldorsson BV, Gretarsdottir S, et al. New sequence variants associated with bone mineral density. Nat Genet. 2009;41:15–17.
- Varley I, Hughes DC, Greeves JP, et al. RANK/RANKL/OPG pathway: Genetic associations with stress fracture period prevalence in elite athletes. Bone. 2015;71:131–136.
- Dong SS, Liu XG, Chen Y, et al. Association analyses of RANKL/RANK/OPG gene polymorphisms with femoral neck compression strength index variation in Caucasians. Calcif Tissue Int. 2009;85:104–112.
- De Laet C, Kanis JA, Oden A, et al. Body mass index as a predictor of fracture risk: A meta-analysis. Osteoporos Int. 2005;16:1330–1338.
- Reid IR. Fat and bone. Arch Biochem Biophys. 2010;503:20–27.
- Johansson H, Kanis JA, Odén A, et al. A meta-analysis of the association of fracture risk and body mass index in women. J Bone Miner Res. 2014;29:223–233.
- Lu Y, Pengyuan L, Recker RR, et al. TNFRSF11A and TNFSF11 are associated with age at menarche and natural menopause in white women. Menopause. 2010;17:1048–1054.
- Cosman F, de Beur SJ, LeBoff MS, et al. Clinician's guide to prevention and treatment of osteoporosis. Osteoporos Int. 2014;25:2359–2381.
- Parker SE, Troisi R, Wise LA, et al. Menarche, menopause, years of menstruation, and the incidence of osteoporosis: the influence of prenatal exposure to diethylstilbestrol. J Clin Endocrinol Metab. 2014;99:594–601.
- Yang S, Nguyen ND, Center JR, et al. Association between hypertension and fragility fracture: a longitudinal study. Osteoporos Int. 2014;25:97–103.
- El-Bikai R, Tahir MR, Tremblay J, et al. Association of age-dependent height and bone mineral density decline with increased arterial stiffness and rate of fractures in hypertensive individuals. J Hypertens. 2015;33:727–735.
- Janghorbani M, Van Dam RM, Willett WC, et al. Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture. Am J Epidemiol. 2007;166:495–505.
- Jackuliak P, Payer J. Osteoporosis, fractures, and diabetes. Int J Endocrinol. 2014;2014:820615.
- Majumdar SR, Leslie WD, Lix LM, et al. Longer duration of diabetes strongly impacts fracture risk assessment: the Manitoba BMD Cohort. J Clin Endocrinol Metab. 2016;101:4489–4496.